Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2019 11:00 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Fourth Quarter 2018 Financial Report

Hofseth BioCare had operating revenues of NOK 14.3m (26.4m) in the fourth quarter of 2018. Sales revenues for 2018 amounted to NOK 60.6m (66.2m). Cost of Goods Sold (CoGS) amounted to NOK 9.9m...
January 24, 2019 08:43 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: CORRECTION: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA

Hofseth AS, a 100 % owned company of Hofseth International AS (partly, indirectly owned by CEO Roger Hofseth and Chairman of the Board Ola Holen), has today received 157,687 shares in Hofseth BioCare...
January 24, 2019 08:15 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA

Hofseth AS, a 100 % owned company of Hofseth International AS (partly, indirectly owned by CEO Roger Hofseth and Chairman of the Board Ola Holen), has today received 185,714 shares in Hofseth BioCare...
December 10, 2018 05:52 ET | Source: Hofseth Biocare ASA

Hofseth BioCare ASA: NEW STUDY SHOWS CALGO® IS SUPERIOR TO TRADITIONAL CALCIUM SOURCES ON OSTEOBLAST AND CALCIUM DEPOSITION

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA (HBC) produces CalGo®,...
November 02, 2018 03:02 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Third Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare had operating revenues of NOK...
September 26, 2018 05:31 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: REGISTRATION OF SHARE CAPITAL INCREASE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
September 11, 2018 08:36 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: Result of the subsequent offering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange...
September 10, 2018 02:15 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: LAST DAY OF SUBSCRIPTION PERIOD

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
September 06, 2018 03:05 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: New study and US provisional patent filed on regulation of oxidative protective genes in human cells with ProGo for treatment of IBD, such as ulcerative colitis and Crohn's

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} An invitro study on the regulation of...
August 27, 2018 10:17 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Second Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA had operating revenues of...